613 related articles for article (PubMed ID: 10537067)
1. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
Takahashi M; Yasutake K; Tomizawa K
J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
[TBL] [Abstract][Full Text] [Related]
2. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
Lucas JJ; Hernández F; Gómez-Ramos P; Morán MA; Hen R; Avila J
EMBO J; 2001 Jan; 20(1-2):27-39. PubMed ID: 11226152
[TBL] [Abstract][Full Text] [Related]
3. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta.
Isagawa T; Mukai H; Oishi K; Taniguchi T; Hasegawa H; Kawamata T; Tanaka C; Ono Y
Biochem Biophys Res Commun; 2000 Jun; 273(1):209-12. PubMed ID: 10873588
[TBL] [Abstract][Full Text] [Related]
4. Distribution of tau protein kinase I/glycogen synthase kinase-3beta, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain.
Takahashi M; Tomizawa K; Ishiguro K
Brain Res; 2000 Feb; 857(1-2):193-206. PubMed ID: 10700568
[TBL] [Abstract][Full Text] [Related]
5. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
[TBL] [Abstract][Full Text] [Related]
6. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
8. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.
Takashima A; Honda T; Yasutake K; Michel G; Murayama O; Murayama M; Ishiguro K; Yamaguchi H
Neurosci Res; 1998 Aug; 31(4):317-23. PubMed ID: 9809590
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of tau at serine 416 by Ca2+/calmodulin-dependent protein kinase II in neuronal soma in brain.
Yamamoto H; Hiragami Y; Murayama M; Ishizuka K; Kawahara M; Takashima A
J Neurochem; 2005 Sep; 94(5):1438-47. PubMed ID: 16000144
[TBL] [Abstract][Full Text] [Related]
10. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain.
Hoshi M; Takashima A; Noguchi K; Murayama M; Sato M; Kondo S; Saitoh Y; Ishiguro K; Hoshino T; Imahori K
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2719-23. PubMed ID: 8610107
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
Hagen T; Vidal-Puig A
Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of GSK-3beta corrects phenotypic aberrations of dorsal root ganglion cells, cultured from adult transgenic mice overexpressing human protein tau.
Nuydens R; Van Den Kieboom G; Nolten C; Verhulst C; Van Osta P; Spittaels K; Van den Haute C; De Feyter E; Geerts H; Van Leuven F
Neurobiol Dis; 2002 Feb; 9(1):38-48. PubMed ID: 11848683
[TBL] [Abstract][Full Text] [Related]
13. Involvement of glycogen synthase kinase-3beta and tau phosphorylation in neuronal Golgi disassembly.
Elyaman W; Yardin C; Hugon J
J Neurochem; 2002 May; 81(4):870-80. PubMed ID: 12065646
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3beta in N1E-115 neuroblastoma cells.
Ishii T; Furuoka H; Muroi Y; Nishimura M
J Biol Chem; 2003 Jul; 278(29):26970-5. PubMed ID: 12714590
[TBL] [Abstract][Full Text] [Related]
15. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
Imahori K; Uchida T
J Biochem; 1997 Feb; 121(2):179-88. PubMed ID: 9089387
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.
Selenica ML; Jensen HS; Larsen AK; Pedersen ML; Helboe L; Leist M; Lotharius J
Br J Pharmacol; 2007 Nov; 152(6):959-79. PubMed ID: 17906685
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons.
Forlenza OV; Spink JM; Dayanandan R; Anderton BH; Olesen OF; Lovestone S
J Neural Transm (Vienna); 2000; 107(10):1201-12. PubMed ID: 11129110
[TBL] [Abstract][Full Text] [Related]
20. In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3beta in neuronal apoptosis: links to tau phosphorylation.
Elyaman W; Terro F; Wong NS; Hugon J
Eur J Neurosci; 2002 Feb; 15(4):651-60. PubMed ID: 11886446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
